Showing results (161-170 of 333) with videos related to

Sort By:
Pageof 34
Blood Cancer Discovery|February 4, 2026
Seeing Is Believing: IEC-HS after CAR T CellsJoseph M Rocco, Nirali N Shah
Blood Cancer Discovery|January 26, 2026
Incorporation of genomic determinants improves diagnostic accuracy of oligomonocytic chronic myelomonocytic leukemiaGuillermo Montalban-Bravo, Chong Wu, Juan Jose Rodriguez-Sevilla, et al.
Blood Cancer Discovery|September 4, 2025
Timing genomic antigen loss in multiple myeloma treated with T-cell redirecting immunotherapiesMarios Papadimitriou, Sungwoo Ahn, Benjamin T Diamond, et al.
Blood Cancer Discovery|May 9, 2022
The Cell Type-Specific 5hmC Landscape and Dynamics of Healthy Human Hematopoiesis and TET2-Mutant PreleukemiaYusuke Nakauchi, Armon Azizi, Daniel Thomas, et al.
Blood Cancer Discovery|January 18, 2021
Sphingosine-1-phosphate receptor 3 potentiates inflammatory programs in normal and leukemia stem cells to promote differentiationStephanie Z Xie, Kerstin B Kaufmann, Weijia Wang, et al.
Blood Cancer Discovery|November 15, 2021
Disease- and Therapy-Specific Impact on Humoral Immune Responses to COVID-19 Vaccination in Hematologic MalignanciesDavid J Chung, Gunjan L Shah, Sean M Devlin, et al.
Blood Cancer Discovery|November 15, 2021
Aberrant Extrafollicular B Cells, Immune Dysfunction, Myeloid Inflammation, and MyD88-Mutant Progenitors Precede Waldenstrom MacroglobulinemiaAkhilesh Kaushal, Ajay K Nooka, Allison R Carr, et al.
Blood Cancer Discovery|November 15, 2021
NOT-Gated CD93 CAR T Cells Effectively Target AML with Minimized Endothelial Cross-ReactivityRebecca M Richards, Feifei Zhao, Katherine A Freitas, et al.
Blood Cancer Discovery|March 8, 2021
A Therapeutic Strategy for Preferential Targeting of TET2 Mutant and TET-dioxygenase Deficient Cells in Myeloid NeoplasmsYihong Guan, Anand D Tiwari, James G Phillips, et al.
Blood Cancer Discovery|January 11, 2022
Modulation of CD22 Protein Expression in Childhood Leukemia by Pervasive Splicing Aberrations: Implications for CD22-Directed ImmunotherapiesSisi Zheng, Elisabeth Gillespie, Ammar S Naqvi, et al.
Pageof 34